Brightenex ™ from ZO® Medical Features New Oleosome Technology

Brightenex™ becomes the first product to market this advanced delivery system targeting hyperpigmentation and sun damage

May 15, 2012, 06:31 ET from ZO Skin Health, Inc.

IRVINE, Calif., May 15, 2012 /PRNewswire/ -- ZO Skin Health, Inc. is delighted to reveal that the new ZO® Medical Brightenex™ skin brightener and correcting creme incorporates revolutionary Oleosome technology to deliver superior results as a safer alternative to hydroquinone for brighter and more even toned skin.

ZO® Medical's Brightenex™ is bioengineered to target all four stages of skin discoloration through a patented, bio-vectored, micro-sphere delivery system. Experts recommend Brightenex™ as the first course in effectively treating hyperpigmentation.

Dr. Zein Obagi says "Move over Hydroqinone! ZO Skin Health, Inc. has found a new way to inhibit melanogenisis and reverse hyper pigmentation."

Brightenex™ is positioned to lead the category of topical hyperpigmentation solutions. It is the first commercial product launch that stabilizes pure retinol (1.0%), melanin inhibitors and antioxidants with natural, patented Oleosome technology. Oleosomes are microspheres of antioxidant-rich emollient oils and vitamins found naturally in plant seeds like almond and safflower. As these microspheres release, they provide immediate moisturization benefits to skin. By stabilizing and delivering retinol, Oleosome technology also provides a delayed release of active ingredients, reducing potential irritation while improving performance.

"We expect Brightenex™ to be one of our key selling ZO® Medical products, out pacing conventional hydroquinone," says Deborah Tomes, Vice President of Domestic and International Marketing. "It's a revolutionary formula that was developed under the direction of Dr. Obagi."

Brightenex™ retails for $110. ZO® Medical products are exclusively available through leading physician practices throughout the U.S. and Canada.

About Zein Obagi, MD
Researcher, innovator, scientist, published author, lecturer and board-certified dermatologist, Dr. Zein Obagi has achieved international renown as a leading authority on skin rejuvenation. He is the ZO Skin Health, Inc. founder and medical director and is responsible for the development of new skincare treatments, protocols and products to achieve healthy skin.

Twenty years ago, Dr. Zein Obagi pioneered the concept of skin health and conceived of, and brought to market, a line of medical skincare products – the original Obagi Nu-Derm® System – that transformed aging skin.  Dr. Obagi founded WorldWide Products, which produced and marketed the original Obagi Nu-Derm® System.  At that time, Dr. Obagi merely intended to challenge the norms of traditional skin care.  Instead he shattered the status quo.  Today his ideas about skin health are no longer surprising; they have become mainstream.  Subsequently WorldWide was purchased by Obagi Medical Products, Inc., a company that Dr. Obagi no longer has any affiliation, while Obagi Medical Products retained his family name (Obagi®) as their trademark.  He now has identified his new line with his full name, Zein Obagi MD.

ZO Skin Health, Inc. and Dr. Obagi have no business relationship with Obagi Medical Products, and Obagi Medical Products does not sell or endorse using any ZO® product.  "ZO" is a registered trademark of ZO Skin Health, Inc.  "Obagi" is a registered trademark of Obagi Medical Products, Inc. 

SOURCE ZO Skin Health, Inc.